Akèy › Timè nan sèvo › Nebraska
Etid klinik pou Timè nan sèvo nan Nebraska
5 etid pou Timè nan sèvo ap chèche patisipan nan sit nan Nebraska.
Vil nan Nebraska
Tèks ofisyèl etid la (Anglè)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Cancer Partners of Nebraska - Pine Lake, Lincoln
- Southeast Nebraska Cancer Center - 68th Street Place, Lincoln
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- University of Nebraska, Omaha
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT04222062Assessment of Eloquent Function in Brain Tumor Patients
- University of Nebraska Medical Center, Omaha
Ap rekriteEtid obsèvasyon
Laj 19 ak plis · Tout sèks · Mizajou Jan 13, 2026 · NCT01535430Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.